Latest Articles

Publication Date
All News Scientific
Christian Marth on a First-Line Chemotherapy-Free Option for Advanced Endometrial Cancer - Medpage Today

Christian Marth on a First-Line Chemotherapy-Free Option for Advanced Endometrial Cancer Medpage Today

Published: Feb. 5, 2025, 5:54 p.m.
Read Full Article
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial - Medpage Today

First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial Medpage Today

Published: Feb. 5, 2025, 5:54 p.m.
Read Full Article
FDA Grants Breakthrough Device Designation to ACR-368 OncoSignature Assay for Endometrial Cancer - OncLive

FDA Grants Breakthrough Device Designation to ACR-368 OncoSignature Assay for Endometrial Cancer OncLive

Published: Feb. 5, 2025, 5:17 p.m.
Read Full Article
A Case of Postoperative Lymphatic Ascites in Endometrial Cancer Spontaneously Resolving After Approximately One Year of Watchful Waiting - Cureus

A Case of Postoperative Lymphatic Ascites in Endometrial Cancer Spontaneously Resolving After Approximately One Year of Watchful Waiting Cureus

Published: Feb. 5, 2025, 1:26 p.m.
Read Full Article
Acrivon Therapeutics Announces FDA has Granted Breakthrough Device Designation for ACR-368 OncoSignature Assay for Endometrial Cancer - The Manila Times

Acrivon Therapeutics Announces FDA has Granted Breakthrough Device Designation for ACR-368 OncoSignature Assay for Endometrial Cancer The Manila Times

Published: Feb. 5, 2025, 1:07 p.m.
Read Full Article
Targeting the splicing factor SNRPB inhibits endometrial cancer progression by retaining the POLD1 intron - Nature.com

Targeting the splicing factor SNRPB inhibits endometrial cancer progression by retaining the POLD1 intron Nature.com

Published: Feb. 5, 2025, 11:37 a.m.
Read Full Article
Survival Outcomes in Advanced Endometrial Cancer with Lenvatinib plus Pembrolizumab - Physician's Weekly

Survival Outcomes in Advanced Endometrial Cancer with Lenvatinib plus Pembrolizumab Physician's Weekly

Published: Feb. 4, 2025, 11:09 a.m.
Read Full Article
Judge Indicates 40 Hair Relaxer Lawsuits Over Uterine Cancer, Endometrial Cancer and Ovarian Cancer Will Be Selected for Early Trial Program - AboutLawsuits.com

Judge Indicates 40 Hair Relaxer Lawsuits Over Uterine Cancer, Endometrial Cancer and Ovarian Cancer Will Be Selected for Early Trial Program AboutLawsuits.com

Published: Feb. 3, 2025, 9:15 p.m.
Read Full Article
Endometrial Cancer and Mental Health: Challenges and Finding Support - Healthline

Endometrial Cancer and Mental Health: Challenges and Finding Support Healthline

Published: Feb. 3, 2025, 5:51 p.m.
Read Full Article
Potential biomarkers and immune infiltration linking endometriosis with recurrent pregnancy loss based on bioinformatics and machine learning.

Endometriosis (EMs) is a chronic inflammatory disease characterized by the presence of endometrial tissue in the non-uterine cavity, resulting in dysmenorrhea, pelvic pain, and infertility. Epidemiologic data have suggested the …

Published: Feb. 3, 2025, midnight
Read Full Article
biomarker endometrial cancer endometriosis immune infiltration recurrent pregnancy loss
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!